Science Explorer Interactive view Map
Company · Buffalo · United States

Therapyx (United States)

Research works
3
fractional, all time
Citations
34
12.6 per fractional work
Top-10% rate
15.8%
record average 16.5%
Open access
95%
world 28%

Not ranked overall: Therapyx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Therapyx (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Immune Cell Function and Interaction and Bacterial Infections and Vaccines.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 T-cell and B-cell Immunology Immunology 0 works
  3. 3 Immune Cell Function and Interaction Immunology 0 works
  4. 4 Bacterial Infections and Vaccines Microbiology 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Reproductive tract infections research Microbiology 0 works
  7. 7 Reproductive System and Pregnancy Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available95.4%not open4.6%

World: 28% of research is openly available.

with international co-authors41.4%domestic only58.6%

World: 19% is written across borders.

How has Therapyx (United States)'s research output changed?

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Buffalo

All research institutions in Buffalo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.